Sees Q4 adjusted EBITDA between $6.8 million and $8.8 million. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on HCAT: Health Catalyst reports Q3 EPS 7c, consensus 10c Health Catalyst price target raised to $10 from $8 at Evercore ISI Disclaimer & DisclosureReport an Issue
